Product Name:3,3'-Diindolylmethane; 3,3'-Methylenebisindole
CAS NO:1968-05-4
Molscular Formula:C17H14N2
Molscular Weight:246.31
Appearance: white powder
Specification: 99%
Melting Point: < 165°C
Loss on drying (100°C) < 1.0%
Sulfate: < 0.2%
Heavy metals: < 0.001%
Assay (by HPLC) > 98.0%
Acetonitrile (GC) < 400 ppm
Ethanol (GC) < 5000 ppmDIM has the biological properties listed in the chart below. Because of its various potent anti-cancer properties, the National Cancer Institute of the United States has begun clinical trials of DIM as a therapeutic for numerous forms of cancer. Due to its innate immune-modulating properties (potentiation of interferon gamma receptors and production), DIM is also under investigation as a treatment for a variety of viral infections and antibiotic resistant bacteria. As DIM has been demonstrated to synergize with Interferon-Gamma in the potentiation of the major histocompatibility complex, it is currently also under investigation as an adjuvant to IFN-G treatment models for both cancer and viral infections such as HIV, HPV and hepatitis.
Statistics: Companies: 642,000+, Trade Leads: 160,500+, Products: 104,300+, Contacts / Replies: 8,278,500+ There are currently 12359 users online browsing our B2B network. 17:45 GMT, Wednesday, April 24, 2024 Privacy Policy Important Notice! TradeHolding.com B2B Network does not provide an escrow service! Any member who asks you to pay for their products by Western Union to an agent of "TradeHolding.com B2B Network" is fraud and should be immediately reported to us. Do not pay anything to any member who states your money will be added to TradeHolding.com safety deposit account!
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and BR.TradeHolding.com and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.